EP Patent

EP1343478B1 — Induced phase transition method for the production of microparticles containing hydrophilic active agents

Assigned to Alrise Biosystems GmbH · Expires 2007-10-10 · 19y expired

What this patent protects

Microparticles and a method for their production is described. The process of the present invention provides a simple, quick, and efficient one-pot process for the production of microparticles containing a hydrophilic active agent of various and uniform morphologies, including mi…

USPTO Abstract

Microparticles and a method for their production is described. The process of the present invention provides a simple, quick, and efficient one-pot process for the production of microparticles containing a hydrophilic active agent of various and uniform morphologies, including microcapsules, microspheres, and microsponges. The microparticles are preferably used for pharmaceutical applications.

Drugs covered by this patent

Patent Metadata

Patent number
EP1343478B1
Jurisdiction
EP
Classification
Expires
2007-10-10
Drug substance claim
No
Drug product claim
No
Assignee
Alrise Biosystems GmbH
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.